Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction
Clinical trial NCT04984954 · UNKNOWN
Trial details
- NCT number
- NCT04984954
- Sponsor
- Shanghai Hutchison Pharmaceuticals Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2023-12-31
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.